Anumeda - Company finances
|
EUR
|
2019
From: 2019-10-22
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 9,016 | 59,788 | 65,904 | 202,510 | 299,227 | 242,639 | 283,548 |
| Profit before tax | 7,496 | 43,335 | 32,479 | 98,083 | 7,091 | 24,279 | 33,035 |
| Net profit | 7,496 | 43,335 | 32,479 | 98,083 | 7,091 | 22,952 | 30,897 |
| Equity | 10,006 | 53,341 | 85,820 | 183,903 | 190,912 | 213,864 | 244,761 |
| Liabilities | 436 | 3,833 | 31,380 | 20,000 | 42,158 | 54,495 | 41,108 |
| Non-current assets | 2,189 | 9,574 | 69,615 | 56,161 | 201,220 | 237,031 | 202,506 |
| Current assets | 7,533 | 45,560 | 45,545 | 144,726 | 27,850 | 31,328 | 83,363 |
| Total assets | 9,722 | 55,134 | 115,160 | 200,887 | 229,070 | 268,359 | 285,869 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 8,566 | 21,209 | 42,878 |
| Social insurance contributions | - | - | - | - | - | 7,403 | 12,423 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +563.1% | +10.2% | +207.3% | +47.8% | -18.9% | +16.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 77.1% | 78.6% | 28.2% | 48.8% | 3.1% | 8.6% | 10.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 74.9% | 81.2% | 37.8% | 53.3% | 3.7% | 10.7% | 12.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 83.1% | 72.5% | 49.3% | 48.4% | 2.4% | 9.5% | 10.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 83.1% | 72.5% | 49.3% | 48.4% | 2.4% | 10.0% | 11.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.4 | 0.1 | 0.2 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,016 | 47,830 | 32,952 | 101,255 | 143,631 | 44,116 | 44,771 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Anumeda - Social security debts
The company had no debts to Sodra
Anumeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-19 | 2026-03-22 | 0.32 |
| 2026-03-11 | 2026-03-12 | 0.32 |
| 2026-03-08 | 2026-03-10 | 23.08 |
| 2026-03-02 | 2026-03-07 | 836.08 |
| 2026-02-11 | 2026-02-18 | 344.83 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Anumeda, UAB (code 305295881) is a Private Limited Liability Company engaged in other specialised construction activities in buildings. In 2025, the company generated revenue of €283.5K, up 16.9% year on year, while still remaining below the 2023 level of €299.2K. Net profit increased to €30.9K in 2025 from €23.0K in 2024 and €7.1K in 2023, indicating a clear improvement in profitability over the last three years. The profit margin rose to 10.9% in 2025 from 9.5% in 2024 and 2.4% in 2023. Balance sheet strength also improved: total assets reached €285.9K, equity €244.8K and liabilities €41.1K at the end of 2025. The equity ratio stood at 85.6%, with debt-to-equity at 0.17, reflecting a conservative capital structure. Return on equity was 12.6% and return on assets 10.8%. Asset turnover was 0.99x, and revenue per employee was €47.3K, with profit per employee at €5.2K.